Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$17.83 -2.26%

-$0.34 today

Market cap
$966.13M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.79M

Average 1.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$464.13M

FY 2025 · Annual

+224.8% YoY

Liabilities

$628.44M

FY 2025 · Annual

+1259.5% YoY

Equity

-$164.31M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents119.8M57.71M31.36M81.95M396.49M
Short-term Investments87.67M172.54M105.82M9.98M58.72M
Net Receivables00000
Inventory00000
Other Current Assets2.09M2.34M475K380K1.75M
Total Current Assets214.4M236.95M140.8M96.51M458.11M
Property, Plant & Equipment (Net)22.52M57.08M50.1M41.59M3.47M
Goodwill00000
Intangible Assets00000
Long-term Investments02.41M2.41M00
Tax Assets0011.7M00
Other Non-current Assets5.67M2.93M4.81M4.8M2.55M
Total Non-current Assets28.19M62.42M69.03M46.38M6.02M
Total Assets242.59M299.37M209.83M142.89M464.13M
Account Payables1.55M1.77M815K1.51M5.13M
Short-term Debt003.83M0280K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities434K4.95M4.97M6.21M15.33M
Total Current Liabilities10.15M13.12M15.57M18.61M25.17M
Long-term Debt00000
Deferred Tax Liabilities0011.7M00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000600.55M
Total Non-current Liabilities16.17M35.64M43.53M27.62M603.27M
Total Liabilities26.33M48.76M59.1M46.23M628.44M
Common Stock4K7K7K13K18K
Retained Earnings(130.12M)(222.22M)(340.08M)(456.99M)(1.15B)
Accumulated OCI0(770K)(77K)22K41K
Other Stockholders Equity(1K)0000
Minority Interest00000
Total Equity216.26M250.61M150.72M96.66M(164.31M)
Total Debt18.01M38.91M35.66M31.83M3M
Net Debt(101.79M)(18.79M)4.3M(50.12M)(393.49M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$169.9M
Short-term Investments$321.7M
Other Current$9.3M
Total Current Assets$500.8M
PP&E (Net)$3.4M
Other Non-current$2.6M
Total Non-current Assets$6.0M
Total Assets$506.7M

Analysis

Selected assets total $506.7M for Latest. The largest visible component is Short-term Investments at $321.7M, about 63.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
424B5424B5 filingOct 30, 2026
10-QQuarterly reportOct 30, 2026

How much cash does VOR have?

Vor Biopharma Inc. (VOR) reported $396.49M in cash and equivalents in fiscal 2025.

How much debt does VOR carry?

Vor Biopharma Inc. (VOR) reported $3.00M of total debt, with net debt of -$393.49M.